Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor-F Mautner

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|June 9, 2012
Adhesion molecule L1 is down-regulated in malignant peripheral nerve sheath tumors versus benign neurofibromatosis type 1-associated tumorsMarco Blessmann, Alexander Gröbe, Alexander Quaas, et al.
Brain Pathology (Zurich, Switzerland)|September 28, 2004
Subclassification of nerve sheath tumors by gene expression profilingNikola Holtkamp, David E Reuss, Isis Atallah, et al.
Plos One|March 17, 2015
Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patientKarolina Kobus, Daniela Hartl, Claus Eric Ott, et al.
Oncotarget|January 19, 2013
Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibitionPooja Mohan, Joan Castellsague, Jihong Jiang, et al.
European Journal of Human Genetics : EJHG|October 9, 2014
Somatic neurofibromatosis type 1 (NF1) inactivation events in cutaneous neurofibromas of a single NF1 patientDenise Emmerich, Tomasz Zemojtel, Jochen Hecht, et al.
Human Genetics|March 13, 2016
No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patientsSonja Hutter, Rosario M Piro, Sebastian M Waszak, et al.
Molecular and Cellular Biology|May 6, 2009
Ral overactivation in malignant peripheral nerve sheath tumorsVidya Bodempudi, Farnaz Yamoutpoor, Weihong Pan, et al.
Neurology|August 17, 2016
Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosisShivani Ahlawat, Laura M Fayad, Muhammad Shayan Khan, et al.
Epilepsia|September 27, 2003
Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European familiesRoberto Michelucci, Juan Jose Poza, Vito Sofia, et al.
Neuro-Oncology|June 3, 2022
Management of neurofibromatosis type 1-associated plexiform neurofibromasMichael J Fisher, Jaishri O Blakeley, Brian D Weiss, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|June 9, 2012
Adhesion molecule L1 is down-regulated in malignant peripheral nerve sheath tumors versus benign neurofibromatosis type 1-associated tumorsMarco Blessmann, Alexander Gröbe, Alexander Quaas, et al.
Brain Pathology (Zurich, Switzerland)|September 28, 2004
Subclassification of nerve sheath tumors by gene expression profilingNikola Holtkamp, David E Reuss, Isis Atallah, et al.
Plos One|March 17, 2015
Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patientKarolina Kobus, Daniela Hartl, Claus Eric Ott, et al.
Oncotarget|January 19, 2013
Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibitionPooja Mohan, Joan Castellsague, Jihong Jiang, et al.
European Journal of Human Genetics : EJHG|October 9, 2014
Somatic neurofibromatosis type 1 (NF1) inactivation events in cutaneous neurofibromas of a single NF1 patientDenise Emmerich, Tomasz Zemojtel, Jochen Hecht, et al.
Human Genetics|March 13, 2016
No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patientsSonja Hutter, Rosario M Piro, Sebastian M Waszak, et al.
Molecular and Cellular Biology|May 6, 2009
Ral overactivation in malignant peripheral nerve sheath tumorsVidya Bodempudi, Farnaz Yamoutpoor, Weihong Pan, et al.
Neurology|August 17, 2016
Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosisShivani Ahlawat, Laura M Fayad, Muhammad Shayan Khan, et al.
Epilepsia|September 27, 2003
Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European familiesRoberto Michelucci, Juan Jose Poza, Vito Sofia, et al.
Neuro-Oncology|June 3, 2022
Management of neurofibromatosis type 1-associated plexiform neurofibromasMichael J Fisher, Jaishri O Blakeley, Brian D Weiss, et al.
Pageof 8